JUL 12, 2017 07:08 PM PDT

Double-Edged Sword in the Immune System: Autoimmune Disease Versus HIV

WRITTEN BY: Kara Marker

The good news? Scientists discovered a regulatory immune process that wards off “accidental” responses that lead to autoimmune disease. The bad news? The very same process prevents the production of vital anti-HIV antibodies that could make stopping the transition from HIV infection to AIDS a lot easier.

The process is called immunological tolerance, and it’s hugely important for preventing the production of so-called “self-reactive” antibodies that target healthy human cells as if they were dangerous pathogenic cells. It works by destroying immune cells called B cells during development if they are found to be capable of producing self-reactive antibodies.

Immunological tolerance is a double-edged sword; left alone, it prevents autoimmune disease, but manipulating it is also a key avenue for improving the body’s defense against HIV infection. From the University of Colorado School of Medicine, scientists are experimenting with a potential vaccine to stimulate production of broadly neutralizing antibodies (bnAbs) that are missing due to the destruction of certain B cells during immunological tolerance.

Despite the efforts of immunological tolerance, sometimes bnAbs are naturally produced after years of HIV infection. Now, researchers want to speed up the process without putting an HIV-positive person at risk of autoimmune disease.

“Breaching peripheral immunological tolerance permits the production of cross-reactive antibodies able to neutralize HIV-1," explained team leader Professor Raul M. Torres.

As anti-HIV agents, bnAbs recognize a viral protein called Env, which hangs out on the surface of HIV. But bnAbs also recognize the body’s own proteins, which is why it makes sense that the body has a process in place to prevent their production. In past studies, scientists have observed that people with lupus, an autoimmune disease, have lower rates of HIV infection. Even if they do contract HIV, it’s very possible that the high levels of bnAbs in their system keep the infection under control without needing antiretroviral drugs.

Torres and his team began their studying asking this: How can scientists interrupt immunological tolerance to promote bnAb production and, subsequently, a more effective anti-HIV approach? They started with mice genetically altered to exhibit “lupus-like symptoms.” The mice were successfully induced to produce HIV-neutralizing antibodies via the injection of an antibody-promoting chemical called alum.

They continued with normal, healthy mice who were given a drug that impairs immunological tolerance, and the result was the production of HIV-neutralizing antibodies. Production of antibodies was boosted first with an alum injection, followed by injection of the viral protein Env.

 

When HIV-neutralizing antibodies were produced in both mouse studies, levels of self-reactive antibodies recognizing chromosomal protein Histone H2A increased, also confirmed to be capable of neutralizing HIV.

 

"We think this may reflect an example of molecular mimicry where HIV-1 Env has evolved to mimic an epitope on histone H2A as a mechanism of immune camouflage," Torres explained.

Are these experiments and their findings applicable to humans? Torres hopes so, and more studies will have to be conducted for confirmation: “Primary consideration will be determining whether immunological tolerance can be transiently relaxed without leading to detrimental autoimmune manifestations.”

The present study was published in The Journal of Experimental Medicine.

Source: Rockefeller University Press

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 02, 2018
Immunology
MAY 02, 2018
Photographing the Measles Virus
The measles virus was caught leaving infected cells by the scientific paparazzi, that is, experts from Emory Health Sciences using cryo-electron tomography...
MAY 10, 2018
Immunology
MAY 10, 2018
New Biomarker for Lung Cancer Diagnosis
Lung cancer is the most common cause of death from cancer for both genders and for people all over the globe. This is largely due to the lack of diagnostic...
JUN 30, 2018
Immunology
JUN 30, 2018
CD4 T Cells Responsible for Inflammatory Bowel Disease
A specific subset of immune cells could be targeted to better treat inflammatory bowel disease (IBD). A new University of Alabama at Birmingham study point...
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Increased Dose of Drug 'Rifampin' Effective in Eliminating Tuberculosis Bacterium
According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when a...
SEP 07, 2018
Health & Medicine
SEP 07, 2018
What's Behind the Massive Measles Outbreak in Europe?
Measles is a disease that many believe was eradicated years ago. That's true, to a point, but like a bad penny, it's back. In the United States, th...
SEP 11, 2018
Immunology
SEP 11, 2018
Oops! I Broke My DNA
Innate Immune System, DNA Damage and Repair...
Loading Comments...